Clinical Scorecard: Trends in Functional Urological Surgery in England from 2013 to 2024: An Examination of HES Database Insights
At a Glance
Category
Detail
Condition
Benign lower urinary tract dysfunction including BPE, urinary incontinence, post prostatectomy incontinence, and vesicovaginal fistulas
Key Mechanisms
Surgical interventions targeting prostate size, urinary sphincter function, and fistula repair using evolving techniques and guidelines
Target Population
Men and women with benign prostatic enlargement, urinary incontinence (stress, urgency), post prostatectomy incontinence, and vesicovaginal fistulas
Care Setting
NHS hospitals in England, surgical and outpatient settings
Key Highlights
Significant downtrend in surgical tape insertion for female stress urinary incontinence from 2019 onwards, replaced largely by bulking agents.
Introduction and guideline incorporation of newer BPE surgical techniques such as HoLEP, PVP, UroLift, Rezum, and Aquablation over the last decade.
Surgical management of urinary incontinence and post prostatectomy incontinence tailored by severity and patient preference, with artificial urinary sphincter as gold standard for moderate-to-severe PPI.
Guideline-Based Recommendations
Diagnosis
Use of clinical assessment and prostate size evaluation to guide BPE surgical options.
Classification of urinary incontinence type (stress, urgency, mixed) to determine appropriate surgical intervention.
Assessment of post prostatectomy incontinence severity to select suitable surgical management.
Management
TURP remains standard for prostates 30-80 mL; bipolar TURP preferred to reduce TUR syndrome risk.
Holmium laser enucleation (HoLEP) recommended for large prostates (>80 mL).
Minimally invasive therapies (UroLift, Rezum) for prostates <80 mL prioritizing ejaculatory function preservation.
For female SUI, options include mid-urethral slings, bulking agents, colposuspension, and autologous slings.
Refractory UUI managed with Botulinum toxin-A injections or sacral neuromodulation.
Artificial urinary sphincter for moderate-to-severe post prostatectomy incontinence; male slings for mild-to-moderate cases.
Surgical repair of vesicovaginal fistulas based on fistula complexity and location.
Monitoring & Follow-up
Monitor postoperative outcomes including continence status and complications.
Track waiting times and length of hospital stay to optimize care delivery.
Evaluate long-term durability and patient satisfaction with newer surgical techniques.
Risks
Potential complications from surgical tapes leading to decreased use following mesh pause.
Risk of TUR syndrome with monopolar TURP, mitigated by bipolar TURP.
Surgical risks associated with open prostatectomy reserved for very large prostates.
Complications from vesicovaginal fistula repair depending on fistula complexity.
Patient & Prescribing Data
Patients undergoing surgical management for BPE, urinary incontinence, post prostatectomy incontinence, and vesicovaginal fistula repair in NHS England
Marked reduction in mid-urethral tape insertions for female SUI after 2018 with increased use of bulking agents; steady use of colposuspension; introduction of minimally invasive BPE therapies since 2018; surgical management tailored by patient age and condition severity.
Clinical Best Practices
Adopt shared decision making incorporating patient preference and prostate size in BPE surgical planning.
Prefer bipolar TURP over monopolar to reduce TUR syndrome risk.
Consider minimally invasive therapies for suitable patients to preserve ejaculatory function.
Use artificial urinary sphincter for moderate-to-severe post prostatectomy incontinence for long-term durability.
Employ bulking agents as mainstay treatment for female stress urinary incontinence following decline in tape use.
Ensure accurate clinical coding and data collection to monitor trends and outcomes.
